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Live cell imaging can provide important information on cellular dynamics, however the full 14 
utilisation of this technology has been hampered by the limitation imaging reagents. Metal-15 
based complexes have the potential to overcome many of the issues common to many current 16 
imaging agents. The rhenium (I) based complex fac-[Re(CO)3(1,10-phenanthroline)(4-17 
pyridyltetrazolate)], herein referred to as ReZolve-ER
TM
, shows promise as a live cell 18 
imaging agent with rapid cell uptake, low cytotoxicity, resistance to photobleaching and 19 
compatibility with multicolour imaging. ReZolve-ER
TM
 localised to the nuclear 20 
membrane/endoplasmic reticulum (ER) and allowed the detection of exocytotic events at the 21 
plasma membrane. Thus, we present a new imaging agent for monitoring live cell events in 22 
real time, which is ideal for imaging either short or long time courses.  23 
 24 
Introduction 25 
One of the most exciting advances in cell biology has been the development of technology 26 
for live cell imaging, which enables the visualisation of molecular events in real time. 27 
However, while there have been significant advances in spatial and temporal resolution 28 
imaging, with for example spinning disk, fast scanning and super resolution microscope 29 
technologies [1,2], the field of imaging reagents has struggled to keep pace. This is partially 30 
because the imaging reagent market is undergoing a quantum shift from imaging reagents 31 
that require cell fixation, which is known to generates significant artefacts [3], to those that 32 
enable real time live cell imaging. Reagents for live cell imaging ideally should exhibit in situ 33 
stability, optimal emission/photophysical properties, a large Stokes shift, resistance to 34 
photobleaching, capacity for multicolour/multiple probe imaging and most importantly low 35 
toxicity [4]. Consequently, there is a very high demand for imaging reagents that meet these 36 
criteria to enable effective live cell imaging without perturbing cellular mechanisms.  37 
 38 
There are a range of technical approaches for live cell imaging, including endogenous 39 
fluorescence, genetic expression systems, quantum dots and small fluorescent molecules. 40 
Endogenous fluorescence has been effectively used for in vitro live cell and intravital 41 
imaging [5,6], and while this mode of imaging does not require exogenous labelling there are 42 
only a limited number of molecules capable of generating detectable endogenous 43 
fluorescence [7]. Furthermore, endogenous fluorescence (often referred to as 44 
autofluorescence) can actually be a hindrance when combined with specific microscopy 45 
imaging techniques [8]. While GFP expression systems revolutionised the field of 46 
mammalian cell biology [9,10], this technology requires genetic manipulation of the target. 47 
Moreover, the GFP molecule is large and can cause steric problems that influence molecular 48 
function [11]. In addition, many molecular targets, including carbohydrates and lipids are not 49 
amenable to this technology. While the use of quantum dot imaging is rapidly increasing, this 50 
nanocrystal technology can be prone to particle breakdown, toxicity and high production 51 
costs [12]. To date the majority of the commercially available reagents for fluorescence 52 
imaging have been based on organic compounds, like BODIPY. These compounds can suffer 53 
from a range of issues including concentration dependent fluorescent shifts, photobleaching 54 
and cytotoxicity. To address the growing need for specific, high quality imaging reagents that 55 
do not affect cell viability, researchers have been exploring luminescent metal complexes, 56 
such as those of Re(I), Ru(II), Ir(III), Pt(II) and the trivalent lanthanides [13-16]. Metal 57 
complexes have the potential to overcome a number of the pitfalls associated with organic 58 
fluorophores, as they are typically resistant to photobleaching, allowing excitation for longer 59 
periods of times with respect to organic fluorophores. Moreover, the triplet multiplicity 60 
nature of the excited states of these species implies that their excited state lifetime is usually 61 
elongated, ranging between hundreds of nanoseconds to milliseconds depending on the 62 
structure of the complex. Compared to the fast decay of endogenous autofluorescence, the 63 
transition metal characteristics can be exploited in time-gated imaging techniques, to 64 
improving signal-to-noise ratios. Lastly, the large Stokes shift of luminescent metal 65 
complexes is beneficial to avoid issues with concentration dependent quenching.  66 
 67 
Recently, we have shown that the Re(I) complex fac-[Re(CO)3(phen)(L
3py
)], where phen is 68 
1,10-phenanthroline and L
3py
 is 3-pyridyltetrazolate can be utilised for live cell imaging, and 69 
it localises to acidic vesicles [17]. This complex was also found to be highly resistant to 70 
photobleaching, strongly emissive with a large Stokes shifts and long emission life times, 71 
whilst exhibiting minimal to no cytotoxicity [17]. We have also shown that changes to the 72 
tetrazolate structure result in changes in intracellular distribution, whilst retaining the key 73 
properties for live cell imaging (photobleaching resistant, large Stokes shift, minimal 74 
cytotoxicity). For example the exchange of the L
3py-
 for 4-cyanophenyltetrazolate results in 75 
Re(I) complex (ReZolve-L1
TM
) with shown preferential localisation within the lipid droplet 76 
[17,18]. Therefore, in the interest of designing new Re(I) complexes for cell imaging, we 77 
furthered our investigation of altering the chemical nature of the ancillary ligand to highlight 78 
consequent effects in biological behaviour of the metal-based complex. We have previously 79 
published the synthesis, electrochemical and photophysical properties of the analogous Re(I) 80 
complex bound to the 4-pyridyltetrazolate ligand, herein designated as ReZolve-ER
TM
 [19]. 81 
Remarkably, preliminary investigation into the incubation and localisation of this complex 82 
revealed a different staining pattern with respect to fac-[Re(CO)3(phen)(L
3py
) ], despite the 83 
only difference between the two complexes being the 3- or 4-pyridyl substituent. Intrigued by 84 
this initial finding we continued our investigation and here we show that ReZolve-ER
TM
 85 
localises to the endoplasmic reticulum (ER) [17]. Furthermore we show that ReZolve-ER
TM
 86 
is ideal for live cell imaging applications, with rapid detection within cells, resistance to 87 
photobleaching, consistent cellular localisation and low cytotoxicity. In addition, ReZolve-88 
ER
TM
 allowed the visualisation of specific nuclear events, ER structures and vesicle release 89 
from the cell surface, demonstrating that this compound is suitable for investigating a range 90 
of biological questions related to cellular dynamics. 91 
 92 
Materials and Methods 93 
Cell culture and staining 94 
The non-malignant cell lines PNT1a and PNT2 and prostate cancer cell line LNCaP (clone 95 
FCG) were obtained from the European Collection of Cell Cultures via CellBank Australia 96 
(Children’s Medical Research Institute, NSW, Australia). Prostate cancer cell line DU145, 97 
was obtained from the American Tissue Culture Collection via Cryosite (Cryosite Ltd., New 98 
South Wales, Australia). Chinese hampster ovaries CHO-K1 cell line and Human monocytic 99 
leukemia THP-1 cell line were obtained from the American Type Culture Collection via 100 
Sigma-Aldrich (Sigma-Aldrich, St. Louis, USA). 101 
 102 
The PNT1a, PNT2, CHO-K1 and THP-1 cell lines were maintained in Roswell Park 103 
Memorial Institute (RPMI) 1640 culture medium (Sigma-Aldrich, USA), supplemented with 104 
10% foetal calf serum (In Vitro Technologies, Australia), 2 mM L-glutamine (Sigma-Aldrich, 105 
USA). The DU-145 cell line was cultured in minimum essential medium (Gibco, Life 106 
Technologies, USA), supplemented with 10% foetal calf serum, 2 mM L-glutamine and 1 107 
mM sodium pyruvate (Sigma-Aldrich, USA). The LNCaP cell line was cultured in RPMI-108 
1640 media (Gibco, Life Technologies, USA) supplemented with 2 mM L-glutamine, 10 % 109 
FCS, 10 mM HEPES (Sigma-Aldrich, USA) and 1 mM sodium pyruvate. THP-1 monocytes 110 
were differentiated into macrophages by incubation with RPMI-1640 medium containing 5 111 
ng/mL of phorbol 12-myristate 13-acetate (Sigma-Aldrich, USA) over 48 hours. Cells were 112 
cultured to approximately 90% confluence before passage, by washing with sterile PBS 113 
(Sigma-Aldrich, St. Louis, USA), TrypLE
TM
 Express (Gibco, USA) to dissociate the cells 114 
from the culture surface and then resuspended in supplemented culture medium. Cell lines 115 
were maintained at 37°C and 5% CO2 in a Sanyo MCO-17AI humidified incubator (Sanyo 116 
Electric Biomedical, Japan). For imaging experiment cells were culture in Ibidi µ-slides 8 117 
wells (Ibidi, Germany) and for MTS assays PNT2 cells were cultured in 96 well plates.  118 
 119 
For cellular imaging, cells were incubated with 50 µM ReZolve-ER
TM
 prepared in serum free 120 
cell culture media, from a 10 mM stock solution prepared in DMSO. Cells were then imaged 121 
immediately or following 15 min of incubation without washing cells. For co-staining 122 




 Red CMXRos, 123 
LysoTracker
®
 Red DND-99 or CellMask
TM
 (Molecular Probes, USA), according to the 124 
manufactures instructions. Cells were then washed 2 x 30 sec in PBS. Serum free media 125 
containing 50µM of ReZolve-ER
TM
 was then added and images were collected after 15 126 
minutes of incubation. Cell fixation was performed using 4% paraformaldehyde in PBS for 127 
20 minutes at room temperature. Cells were then washed for 3 x 10 minutes in PBS before 128 
incubation with 50 µM ReZolve-ER
TM
 for 20 minutes.   129 
 130 
Confocal imaging and analysis 131 
For confocal imaging cells were held in a Uno-Combined-Controller, CO2 microscope 132 
electric top stage incubation system (Okolab, Italy) held at 37°C and 5% CO2. Confocal 133 
imaging was performed on a Nikon A1
+
 confocal microscope, fitted with a LU-N4/LU-N4S 134 
4-laser unit (405 nm, 488 nm, 561 nm, 640 nm), the A1-DUG GaAsP Multi Detector Unit (2 135 
GaAsP PMTs + 2 standard PMTs) and a 32 channel spectral detector (Nikon, Japan). Images 136 
were captured using a 60x oil emersion lens. Each confocal micrograph represented 0.5 μm 137 
thin optical sections. 138 
 139 
To assess emission intensity of ReZolve-ER
TM
 over time NIS-Elements software (Nikon, 140 
Japan) was used. Regions of interest were selected using the AutoDetect function to select 141 
cells containing ReZolve-ER
TM
, mean emission intensity was then measured over time for 142 
each region of interest. For each experiment greater than six regions of interest were used to 143 
gain the average emission intensity in Microsoft Excel 2013 (which were then plotted against 144 
time). Co-localisation between ReZolve-ER
TM
 and ER-Tracker® Red, MitoTracker® Red 145 
CMXRos or LysoTracker® Red DND-99 was assessed in NIS-Elements software (Nikon, 146 
Japan) using the co-localisation analysis to generate a Pearson’s correlation coefficient. Cells 147 
from a minimum of 10 images for each marker were measured for co-localisation and the 148 
means were compared by ANOVA analysis in GraphPad Prism with Tukey post-hoc analysis 149 
(Prism software, version 6.01, USA).  150 
Cytotoxicity assay 151 
To assess cytotoxicity of the complexes, cellular NAD(P)H-dependent redox activity was 152 
measured using CellTiter 96
®
 AQueous Non-Radioactive Cell Proliferation Assay (MTS) 153 
according to the manufacturer instruction (Promega, USA). Briefly, PNT2 cells were cultured 154 
as described above in 96 well plates for 24 h. Cells were then incubated with 50 μM of 155 
ReZolve-ER
TM
 for 1 h, 4 h, 8 h or 24 h in serum free media, for a control cells were incubate 156 
with 0.5% v/v DMSO in serum free media for the corresponding incubation time without the 157 
presence of ReZolve-ER
TM
. Media was then removed and replaced by 120 μL of MTS and 158 
PMS in RPMI-1640 medium and allowed to incubate at room temperature for 1 h. The 159 
absorbance was then measured at 490 nm by EnSpire Plate Readers (PerkinElmer, USA). 160 
 161 
Results and discussion 162 
The synthesis and photophysical properties of ReZolve-ER
TM
 have previously been reported 163 
[19]. This complex was found to be compatible with fluorescent microscopy using single 164 
photon excitation at 403 nm or two-photon excitation between 800 nm and 830 nm, making it 165 




 cellular uptake is by passive diffusion.  168 
For effective cellular imaging, reagents need to penetrate the cell membrane and accumulate 169 
in a cell at a high enough concentration for detection by fluorescence microscopy. To assess 170 
this, live non-malignant prostate PNT2 cells were incubated with ReZolve-ER
TM
 at 50 M, 171 
and the emission monitored in real time over 30 minutes (Supplementary Video 1). Using a 172 
Nikon A1 microscope (equipped with a live cell incubator), the emission from ReZolve-173 
ER
TM
 was detected within seconds after the complex was applied, using a low excitation 174 
power (403 nm excitation laser set to < 2 power setting) and a low detector sensitivity (Si 175 
PMT HV detector 180). Initially ReZolve-ER
TM
 could be detected in the cytoplasm, but 176 
within the first minute of addition, the accumulation of the complex could be detected in the 177 
peri-nuclear region. The emission intensity increased throughout the cell over the first 10 178 
minutes. After this time, the intensity and localisation of the complex appeared to be 179 
consistent for the next 20 minutes of image collection. The ability to detect the complex in 180 
cells within seconds of addition, at low laser power, is important as this will prevent photo-181 
damage of live cells and suggested the potential for ReZolve-ER
TM
 as a real time imaging 182 
agent.   183 
 184 
The rapid entry of ReZolve-ER
TM
 into PNT2 cells suggested that this complex was able to 185 
freely transit across the cell membrane. Furthermore, the signal from the ReZolve-ER
TM
 was 186 
concentration dependent, and a concentration of 50 M was optimal for imaging, with lower 187 
concentrations resulting in weaker signal detection. When cells that had been labelled with 188 
ReZolve-ER
TM
 were washed (i.e. media containing ReZolve-ER
TM
 was replaced with fresh 189 
culture medium containing no dye), there was an immediate reduction in the ReZolve-ER
TM
 190 
detection. This suggested that ReZolve-ER
TM
 had a low affinity for its cellular target; and 191 
supported the premise that a passive diffusion mechanism was involved for ReZolve-ER
TM
 192 
cell entry, as this mechanism is dependent on a concentration gradient. To further confirm 193 
this mode of entry, cells were fixed in paraformaldehyde and incubated with ReZolve-ER
TM
. 194 
The complex could be easily detected in these cells following fixation, confirming passive 195 
transport as the mode of cell entry (Supplementary figure 1). The rapid uptake of ReZolve-196 
ER
TM
 is ideal for real time imaging of cells and the ability to control the addition or removal 197 
of the complex may be well suited to the long term monitoring of specific cellular structures.  198 
 199 
To assess the photostability of ReZolve-ER
TM
 in cells, PNT2 cells were incubated with the 200 
complex and imaged continuously using a higher laser power, in an attempt to induce 201 
photobleaching. Images were collected with a scan rate of 0.22 seconds and a pixel dwell 202 
time of 0.22 milliseconds for a total of 448 scans (approximately 29 minutes), with the 203 
excitation power set to a setting of 10, which was five times greater than the maximum power 204 
required for ReZolve-ER
TM
 visualisation. Over the first eight minutes of image collection the 205 
intensity increased as the complex accumulated in cells (Figure 1), as was observed when a 206 
lower laser power was used (Supplementary video 1). Between eight and 29 minutes the 207 
emission intensity remained constant (Figure 1); suggesting that the complex was highly 208 
resistant to photobleaching. However, an increase in emission intensity was observed in the 209 
final minutes of acquisition when using a high laser power (five times the power required for 210 




 is detected at the ER and nucleoplasmic reticulum.  213 
In different cell lines, including non-malignant prostate cells (PNT2 and PNT1a), malignant 214 
prostate cancer cells (LNCaP and DU145), CHO-K1 cells and THP-1 macrophages 215 
(Supplementary Figure 2), ReZolve-ER
TM
 detected a central structure within the nucleus that 216 
resembled the nucleolus, with projections towards the nuclear membrane; as well as a diffuse 217 
reticular network emanating from the nuclear region, which extended into distal regions of 218 
the cell. To further define this intracellular distribution, ReZolve-ER
TM







 (lysosomes/acidic vesicles) 220 
and CellMask™ (plasma membrane) in PNT2 cells. PNT2 cells were labelled with the latter 221 
commercial dyes, the cells were briefly washed and then incubated with 50 M ReZolve-222 
ER
TM
 for 15 to 20 minutes before imaging (Figure 2). ReZolve-ER
TM
 showed significant co-223 
localisation with ER-Tracker®, with a Pearson’s correlation coefficient of 0.84±0.01. Co-224 
localisation between ReZolve-ER
TM
 and ER-Tracker® was observed on the reticular network 225 
extending from the nucleus into the cytoplasm, at the nuclear membrane and on membranous 226 
structures extending into the nucleus that appear to be nucleoplasmic reticulum (Figure 2A). 227 
The nucleoplasmic reticulum has been previously visualised using ER markers, such as ER-228 
Tracker® [20, 21] or ER associated Ca2+-ATPase [22], which was consistent with ReZolve-229 
ER
TM
 detecting a similar, biologically related structure. In contrast, there was only a limited 230 
amount of ReZolve-ER
TM
 detected in association with mitochondria (Figure 2B) and 231 
lysosomes (Figure 2C), which was shown by lower Pearson’s correlation coefficients for co-232 
localisation between ReZolve-ER
TM
 and either MitoTracker® or LysoTracker® of 0.44±0.01 233 
or 0.37±0.01, respectively. While most of the mitochondrial and lysosomal labelling was 234 
independent of ReZolve-ER
TM
 some overlap was detected between these structures (Figure 235 
2B, 2C). This overlap between ReZolve-ER
TM
 and mitochondria or lysosomes was not 236 
surprising given the close association between the ER and these two subcellular 237 
compartments [23, 24]. Interestingly, while ReZolve-ER
TM
 did not stain large areas of the 238 
plasma membrane (Figure 2; i.e. limited co-localisation with CellMask
TM
), there was some 239 
specific sites of co-localization with CellMask
TM
 (Figure 5B), which may have identified a 240 
localised interaction between the endoplasmic reticulum and the cell surface.   241 
From this co-location study we propose that ReZolve-ER
TM
 locates to the ER and 242 
biologically related structures, in live cells. The mechanism by which ReZolve-ER
TM
 243 
associates with the nuclear membrane/ER is not currently known, but a similar tricarbonyl 244 
rhenium(I) diimine luminescent complex, ReZolve-L1
TM
, has been shown to localise with 245 
polar lipids in cells [17, 18]. Given that the ER is a major site of lipid synthesis [25], we can 246 
speculate that ReZolve-ER
TM




 remains in ER structures during longer term real time imaging.  249 
For long term imaging experiments it is important for a reagent to be retained in cells over a 250 
long period of time, and to cause minimal to no damage to the cells. PNT2 cells were 251 
incubated with ReZolve-ER
TM
 and imaged for 280 minutes at 10 minute intervals to assess 252 
the compatibility of the complex with long term imaging. Over 280 minutes ReZolve-ER
TM
 253 
remained localised to the perinuclear region of cells (Figure 3A-C). Although the intensity of 254 
the emission from ReZolve-ER
TM
 decreased over time, it was still easily detected at the end 255 
of the time course (Figure 3C, 3D). The decrease in emission intensity was likely due to the 256 
complex being slowly trafficked out of the cell, and not related to photobleaching, as the 257 
complex was photo-resistant and exhibited continuous emission in response to extended laser 258 
exposure (Figure 3). To assess the potential cytotoxic effects of ReZolve-ER
TM
, PNT2 cells 259 
were incubated with the complex for 1, 4, 7 or 24 hours and the cell viability assessed via an 260 
MTS assay (Figure 3E). Cell viability (as indicated by absorbance) was reduced when treated 261 
with ReZolve-ER
TM
 at 50 µM for 1 hour and 4 hours compared to controls, however the 262 
viability was still significantly higher than the negative control (Figure 3E). Although cell 263 
viability was reduced by this complex, cells imaged with ReZolve-ER
TM
 for the 4 hours did 264 
not show morphological changes, which would have indicated cytotoxicity during this time, 265 
thus suggesting that the cytotoxicity of ReZolve-ER
TM
 was low. Interestingly, following 7 266 
hours and 24 hours of incubation with ReZolve-ER
TM
 the cell viability was unchanged when 267 
compared to controls (Figure 3E). While this may be due to complex efflux, it showed that 268 
long term exposure to the ReZolve-ER
TM
 does not affect overall cell survival. The minimal 269 
cytotoxic effects of ReZolve-ER
TM
 and its ability to be detected in cells over a long time 270 
periods make this complex an ideal tool for live cell imaging.   271 
 272 
Detection of nuclear and ER events with ReZolve-ER
TM
.  273 
A number of time series images were collected using ReZolve-ER
TM
 (Figures 4 and 5) and 274 
these revealed inward projections from the nuclear membrane, which resembled a phagocytic 275 
event at the nuclear membrane (Figure 4), as well as a number of small vesicles in the cellular 276 
periphery (Figure 5). Figure 4 shows that ReZolve-ER
TM
 detected the formation of a large ~3 277 
m nuclear membrane derived phagosome that appeared to sequester part of the nucleoplasm 278 
(Supplementary Video 2). ReZolve-ER
TM
 clearly defined the nuclear membrane extension as 279 
well as the phagosome vesicle formation, closure and release event, which was evident 280 
during the 5 minute imaging time course. It is generally accepted that trafficking into and out 281 
of the nucleus occurs through nuclear pores, which is facilitated by the nuclear pore complex 282 
[26], but budding and formation of vesicles can also occur from the nuclear envelope [27-29]. 283 
For example, ribonucleoprotein particles can be exported out of the nucleus in a process 284 
similar to viral capsid nuclear egress, where small vesicles have been observed forming at the 285 
nuclear envelop, before budding out to release their content [27]. In TEM images 286 
multivesicular bodies have also been visualised in close proximity to the nuclear envelope 287 
and in some cases these multivesicular structures appeared to be forming from the nuclear 288 
envelope [28,29]. Although the identity of this nuclear structure is unclear, and we cannot 289 
rule out an artificially induced cellular response to the complex, it seemed that ReZolve-290 
ER
TM
 was able to visualise specific nuclear events in real time, indicating its potential for live 291 
cell imaging applications. 292 
 293 
To further explore the detection of small (< 0.5 m) vesicles by ReZolve-ER
TM
 in the cellular 294 
periphery, a dual labelling time-course experiment was performed using both ReZolve-ER
TM
 295 
and CellMask™. This enabled the simultaneous visualisation of two distinct vesicular events 296 
at the cell surface (Figure 5; Supplementary Video 3). CellMask™ identified a ~ 1 m 297 
diameter vesicle forming over an eight minute time course, involving a membrane protrusion 298 
from the cell surface and then vesicle budding/excision from the plasma membrane; and 299 
interestingly this microvesicle contained a small amount of diffuse ReZolve-ER
TM
 staining in 300 
its lumen (Figure 5B). The detection of ReZolve-ER
TM
 inside the budding vesicle (Figure 5B) 301 
could be consistent with the dissociation of the dye from the membrane into the vesicle (N.B. 302 
cell washing significantly reduced the staining, suggesting that ReZolve-ER
TM
 has a low 303 
affinity for its target); however we could not exclude the possibility that ReZolve-ER
TM
 was 304 
identifying a specific target within these budding vesicles. In addition, a small (< 0.5 m) 305 
vesicle with intense ReZolve-ER
TM
 staining was visualised: first distorting a specific location 306 
on the plasma membrane and showing co-location with CellMask™; and then pushing 307 
through the plasma membrane to be released from the cell (Figure 5C). This later event 308 
occurred more rapidly (~ 2-3 minutes) when compared to the former 1 m diameter vesicle 309 
formation and release (~ 8-9 minutes). These observations suggest that ReZolve-ER
TM
 has 310 
the potential for not only visualising the ER, but also vesicle trafficking out of the cell.  311 
 312 
Conclusion 313 
Visualising cellular organelles such as the ER can provide powerful insights for 314 
understanding cellular dynamics under a range of physiological conditions. The ER plays a 315 
central role in protein transcription, molecular trafficking and cellular signalling. 316 
Endoplasmic reticulum stress is commonly observed in a range of diseases and in response to 317 
physiological stress, and thus the ability to track the ER over large time periods may provide 318 
new insights into diseases such as cancer, non-alcoholic fatty liver disease, diabetes and 319 
neurodegenerative disease. Thus an imaging reagent such as ReZolve-ER
TM
 that can monitor 320 
the ER has potential applications in facilitating our understanding of cell biology in a range 321 
of diseases. Given that ReZolve-ER
TM
 has the ability to be used over short or long time 322 
courses, is highly resistant to photobleaching, can be removed from cells, has low 323 
cytotoxicity over long exposure times and has already demonstrated its ability to detected 324 
interesting cellular phenomena in real time, this imaging reagent could be utilised in a 325 
multitude of experimental protocols and provide a flexible imaging tool for cell biologists.  326 
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 does not photobleach when expose to high laser power. (A-C) 410 
Confocal micrographs of PNT2 cells incubated with ReZolve-ER
TM
 for 0 min (A), 15 min (B) 411 
or 29 min (C). Overlay shows the regions of interest from which emissions intensity was 412 
measured. (D) Scatter plot showing average emission intensity (au) of ReZolve-ER
TM
 stained 413 
cells from regions of interest indicated. Images collect with 403 nm excitation set to laser 414 
power 10, a scan rate of 0.22 s (give a total of 448 scans over 29.33 min) and a pixel dewell 415 





 subcellular localisation. Confocal micrographs showing PNT2 419 
cells incubated with ReZolve-ER
TM
 (green) and counter stained with (A) ER-Tracker
®
 for the 420 
labelling of ER (red), (B) MitoTracker
®
 for the labelling  of mitochondria (red), (C) 421 
LysoTracker
®
 for the labelling of lysosomes/acidic compartments (red), and (D) CellMask
TM
 422 





 localisation is unchanged over time. 426 
(A-D) Confocal micrographs of PNT2 cell incubated with ReZolve-ER
TM
. Images taken at 20 427 
min (A), 140 min (B) and 290 min (C) incubation time points. (D) Shows a dot plot of 428 
emissions intensity over time. (E) Histrogram of cell viability measured by an MTS assay in 429 
response to incubation with ReZolve-ER
TM
 (Re-ER) at 50µM for 1 h, 4 h, 7 h or 24 h, when 430 
compaired to a negative control of 50% DMSO in culture media (-ive control), a positive 431 
control of cells will full media (+ive control), and time point controls (control) in which cells 432 
were expose to 0.5% DMSO for 1 h, 4 h, 7 h or 24 h. * indicates a significant difference 433 
between the negative control and all other treatment conditions, ** indicates significant 434 
difference between indicated groups.  435 
 436 
 437 
Figure 4. Time lapse confocal imaging of ReZolve-ER
TM
 in PNT2 cells. Time of image 438 
capture is indicated in the right hand corner of each frame; and represents the last five 439 
minutes in a set of three consecutive time courses (i.e. total 15 min). Scale bar = 10 µm. 440 
Enlarged panel shows nuclear phagosome (~ 3 m) forming over the time course and intense 441 





 imaging of vesicle release from the cell surface. Time lapse 445 
confocal micrographs showing PNT2 cells stained with ReZolve-ER
TM
 (green in A, B and C), 446 
counterstained with Cell Mask (purple in A, B and C). (A) Two vesicle release events were 447 
captured, arrow head indicated cross-section of budding vesicle forming which is enlarged in 448 
panel B; arrow indicates budding event at the cell surface which is enlarged in panel C. Time 449 
of capture is indicated in the right hand corner of each frame (A) or above each frame (B and 450 
C). Scale bar =10 µm. 451 
 452 
